PLx Pharma (NASDAQ:PLXP) Stock Passes Above Fifty Day Moving Average of $4.92
PLx Pharma Inc (NASDAQ:PLXP)’s stock price passed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $4.92 and traded as high as $5.30. PLx Pharma shares last traded at $5.18, with a volume of 4,038 shares traded.
Several research firms have commented on PLXP. Zacks Investment Research downgraded shares of PLx Pharma from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. ValuEngine downgraded shares of PLx Pharma from a “hold” rating to a “sell” rating in a research note on Tuesday, February 4th.
The business’s 50 day moving average is $4.93 and its 200 day moving average is $5.07. The stock has a market cap of $47.50 million, a price-to-earnings ratio of -1.53 and a beta of 5.12.
PLx Pharma Company Profile (NASDAQ:PLXP)
PLx Pharma Inc, a late-stage specialty pharmaceutical company, focuses on developing its PLxGuard delivery system to provide various products in the United States. The company's lead product candidates are Vazalore 325 mg and Vazalore 81 mg, which are formulations of aspirin that use the PLxGuard delivery system to reduce acute gastrointestinal (GI) side effects while providing antiplatelet effectiveness for cardiovascular disease prevention.
Featured Article: What is a back-end load?
Receive News & Ratings for PLx Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PLx Pharma and related companies with MarketBeat.com's FREE daily email newsletter.